Clinical Trial Update: Allergy Immunotherapy in the Management of Eosinophilic Esophagitis [NA]

View source ↗

Summary

A clinical trial evaluating allergy immunotherapy for eosinophilic esophagitis has been withdrawn. The sponsor is United States Naval Medical Center, San Diego.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Eosinophilic Esophagitis | NA | Status: WITHDRAWN